Health

  • Air pollution may up risk of neurological disorders: Study
    New York, October 20 (IANS): New research adds to the growing body of evidence that air pollution is significantly associated with an increased risk of hospital admissions for several neurological disorders, including Parkinson's disease, Alzheimer's disease, and other dementias. For the study, published in the journal The Lancet Planetary Health, the research team analysed the link between fine particulate (PM2.5) pollution and neurodegenerative diseases in the US. Parti
  • China's Sinovac vaccine is safe, Brazil institute says
    BEIJING/SAO PAULO, October 20 (Reuters) - An experimental coronavirus vaccine developed by China's Sinovac Biotech appeared to be safe in a late-stage clinical trial in Brazil, preliminary results showed on Monday. São Paulo's Butantan Institute, one of Brazil's leading biomedical research centers, which is carrying out the Phase 3 tests, said the two-dose vaccine, called CoronaVac, proved to be safe in a trial so far involving 9,000 volunteers. But Butantan di
  • First results of Russian coronavirus vaccine trial may include data from 5,000-10,000 people
    MOSCOW, October 20 (Reuters) - Preliminary results from the late-stage human trial of Russia's main coronavirus vaccine candidate could include data from 5,000-10,000 participants, Denis Logunov, a director at the Gamaleya Institute that developed the vaccine, said on Monday. Russia's plan to publish preliminary data about the Sputnik V jab as early as November is likely to make it one of the first vaccine developers to share any data from a final stage trial, known as Phase
  • Have nutritional beverage with exercise for fit body, sharp mind
    New York, October 19 (IANS): Daily exercise, along with nutrient-enriched beverages, can do wonder with improving both physical and cognitive health, researchers have discovered. While exercise alone improved strength and endurance, mobility and stability, those who also consumed the nutritional supplement as part of the study saw all of these improvements and more. "For example, they were better able to retain new information in their working memory and had quicker response
  • WHO warns against complacency in view of declining Covid cases
    New Delhi, October 19 (IANS): The World Health Organisation (WHO) on Monday cautioned against any relaxation of response actions following the recent slight decline in Covid-19 cases in South-East Asia Region, saying the pandemic continues unabated and our response only needs to be strengthened further to curtail virus transmission. "There should be no complacency in view of the declining numbers in recent weeks. The Region still reports large numbers of Covid-19 cases. We need
  • Sputnik V Covid-19 vaccine gets nod for clinical trials in India
    New Delhi, October 17 (IANS): The Drug Controller General of India (DCGI) has granted approval to Dr Reddy's, a global pharmaceutical company headquartered in India, to conduct phase 2 and 3 clinical human trials of the Sputnik V, a Covid-19 vaccine made by Russia. On September 16, the Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Limited had agreed to cooperate on clinical trials and distribution of Sputnik V Covid-19 vaccine in India. Sputnik V, an a
  • Q&A: Where are we in the COVID-19 vaccine race?
    NEW YORK (Reuters) - Drugmakers and research centers around the world are working on COVID-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants well underway. As some companies close in on unveiling their initial findings - with Canadian and European regulators already reviewing early data on some vaccines - the following is what we know about the race to deliver vaccines to help end the coronavirus pandemic that has claimed
  • China's Covid-19 vax is safe, prompts antibody response: Lancet
    Beijing, October 16 (IANS): Chinese Covid-19 vaccine candidate -- BBIBP-CorV -- that is expected to completely inactivate the SARS-CoV-2 virus, is safe and elicits an antibody response, a study published in The Lancet has found. A previous clinical trial reported similar results for a different vaccine that is also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only tested on people aged under 60 years. The latest study reported in The Lancet Infec
  • Pfizer sees emergency use filing for COVID-19 vaccine after U.S. election
    October 16 (Reuters) - Pfizer Inc expects to provide safety data and file for authorization of the COVID-19 vaccine it is developing with German partner BioNTech in late November, delaying any clarity on the vaccine until after the Nov. 3 U.S. presidential election. The regulatory filing for the vaccine could come as soon as safety data is available in the third week of November, Pfizer said, lifting the company's shares and the broader U.S. stock market. The timeline now all
  • People with blood type O may have a lower risk of Covid-19: Study
    London, October 15 (IANS): New research adds to the growing body of evidence that people with blood type 'O' may have a lower risk of Covid-19 infection and reduced likelihood of severe outcomes, including organ complications if they do get sick. Two studies published in the journal Blood Advances suggest that individuals with blood type 'O' may be less vulnerable to Covid-19 infection. "It is very important to consider the proper control group because blood
  • Handwashing an effective tool to prevent Covid, other diseases: WHO
    New Delhi, October 15 (IANS): Ten months into the pandemic, handwashing with soap remains one of our best defences against the virus, along with other public health measures such as maintaining physical distance, avoiding crowded places, practising cough etiquette and wearing a mask wherever recommended. Global Handwashing Day observed annually on October 15 to raise awareness and highlight the importance of handwashing as an effective means of disease prevention -- this year marks
  • Handwashing an effective tool to prevent Covid, other diseases: WHO
    New Delhi, October 15 (IANS): Ten months into the pandemic, handwashing with soap remains one of our best defences against the virus, along with other public health measures such as maintaining physical distance, avoiding crowded places, practising cough etiquette and wearing a mask wherever recommended. Global Handwashing Day observed annually on October 15 to raise awareness and highlight the importance of handwashing as an effective means of disease prevention -- this year marks
  • Russia approves second COVID-19 vaccine after preliminary trials
    MOSCOW, October 14 (Reuters) - Russia has granted regulatory approval to a second COVID-19 vaccine, according to its register of authorised medicines. A delighted President Vladimir Putin announced the news at a government meeting on Wednesday. The jab was developed by the Vector Institute in Siberia and completed early-stage human trials last month. However, results have not been published yet and a large-scale trial, known as Phase III, has not yet begun. "We need to in
  • Sanitising-gel poisoning cases soar among Spanish children amid pandemic
    MADRID, October 14 (Reuters) - The number of Spanish children treated for poisoning after ingesting hand-sanitising gels has rocketed as the product has become ubiquitous during the coronavirus pandemic. The Spanish National Toxicological and Forensic Institute said on Wednesday the total reported intoxications from those gels so far this year, at 874, was almost 10 times the number reported in all of 2019. Children, especially toddlers, accounted for almost two-thirds of the cas
  • Covid immunity may last several months: Study
    Òctober 14 (PTI): Immunity against Covid-19 may persist for at least five months after being infected with the SARS-CoV-2 virus, according to a study led by an Indian-origin researcher in the US. The researchers from the University of Arizona studied the production of antibodies from a sample of nearly 6,000 people infected with the novel coronavirus.  "We clearly see high-quality antibodies still being produced five to seven months after SARS-CoV-2 infection,"
  • Regular exercise in morning may cut cancer risk: Study
    London, October 14 (IANS): If you want to live longer, read on. Researchers have found that that when physical activity is done in the morning throughout lifetime can reduce cancer risk. One potential cause of cancer is circadian disruption, the misalignment of environmental cues (light, food intake, etc.) and our endogenous circadian rhythms. Most studies on circadian disruption and cancer risk focused on night shift work. Recent studies suggest that exposure to light at night a
  • Strain of coronavirus in pigs can jump to humans: Study
    October 14 (PTI): A strain of coronavirus which causes acute diarrhea in piglets may have the potential to spread to humans as well, according to a new study which says the virus could "negatively impact the global economy and human health." According to the researchers, including those from the University of North Carolina at Chapel Hill in the United States, the coronavirus strain, known as swine acute diarrhea syndrome coronavirus (SADS-CoV), emerged from bats and has i
  • Breast cancer cases on rise due to Covid fear: Report
    New Delhi, October 13 (IANS): The country has witnessed a spike in stage two and three breast cancer cases owing to delayed screenings and consultations as patients delay hospital visits due to Covid-19, according to a new report on Tuesday. The report from Indraprastha Apollo Hospital in New Delhi found that women seem to be putting their breast health on the backseat by neglecting their screening and visit to physicians owing to the possibility of contracting Covid-19. "Be
  • Very low risk to newborns from moms with Covid-19: Study
    New York, October 13 (IANS): New research adds to the growing body of evidence that women who have Covid-19 are less likely to pass on the infection to their babies during childbirth if precautions are in place. The findings, published in the journal JAMA Pediatrics, suggest that more extensive measures like separating Covid-19-positive mothers from their newborns and avoiding direct breastfeeding may not be warranted. "Our findings should reassure expectant mothers with Cov
  • Johnson & Johnson pauses Covid-19 vaccine trial
    Washington, October 13 (IANS) US pharmaceutical giant Johnson & Johnson announced that it has temporarily paused its Covid-19 vaccine trial after a participant became unwell. "We have temporarily paused further dosing in all our Covid-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant," Xinhua news agency quoted the company as saying in a statement on Monday. The patient's condition wa